PROTEOMIC ANALYSIS OF PEDIATRIC DIFFUSE ASTROCYTOMAS YIELDS PATHWAYS ASSOCIATED WITH BOTH PROGRESSION-FREE AND OVERALL SURVIVAL

被引：0
|
作者：
Sells, Blake [1 ]
Fleming, Jessica [1 ]
Graham, Richard [2 ]
McElroy, Joseph [1 ]
Haque, Jahar [1 ]
Boue, Daniel [3 ]
Becker, Aline [1 ]
Bell, Erica [1 ]
Finlay, Jonathan [3 ]
Chakravarti, Arnab [1 ]
机构：
[1] Ohio State Univ, Columbus, OH 43210 USA
[2] St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA
[3] Nationwide Childrens Hosp, Columbus, OH USA
来源：
NEURO-ONCOLOGY | 2020年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
HGG-45
引用
收藏
页码：352 / 352
页数：1
相关论文
共 50 条
  • [1] Proteomic biomarkers for overall and progression-free survival in ovarian cancer patients
    Hogdall, Estrid
    Fung, Eric T.
    Christensen, Ib Jarle
    Yip, Christine
    Nedergaard, Lotte
    Engelholm, Svend Aage
    Risum, Signe
    Petri, Anette Lykke
    Lundvall, Lene
    Lomas, Lee
    Hogdall, Claus
    PROTEOMICS CLINICAL APPLICATIONS, 2010, 4 (12) : 940 - 952
  • [2] IDH1 mutation is associated with improved resection rates, progression-free survival and overall survival in patients with anaplastic astrocytomas
    Ahmeti, Hajrullah
    Kiese, Daniel
    Freitag-Wolf, Sandra
    Kalab, Michael
    Roecken, Christoph
    Jansen, Olav
    Mehdorn, Maximilian H.
    Synowitz, Michael
    JOURNAL OF NEURO-ONCOLOGY, 2024, 169 (02) : 423 - 435
  • [3] Clinical factors and conventional MRI may independently predict progression-free survival and overall survival in adult pilocytic astrocytomas
    Shin, Ilah
    Park, Yae Won
    Ahn, Sung Soo
    Kim, Jinna
    Chang, Jong Hee
    Kim, Se Hoon
    Lee, Seung-Koo
    NEURORADIOLOGY, 2022, 64 (08) : 1529 - 1537
  • [4] Clinical factors and conventional MRI may independently predict progression-free survival and overall survival in adult pilocytic astrocytomas
    Ilah Shin
    Yae Won Park
    Sung Soo Ahn
    Jinna Kim
    Jong Hee Chang
    Se Hoon Kim
    Seung-Koo Lee
    Neuroradiology, 2022, 64 : 1529 - 1537
  • [5] Concordance index: Surrogacy of progression-free survival for overall survival
    Fan, Yiwei
    Yin, Guosheng
    CONTEMPORARY CLINICAL TRIALS, 2021, 104
  • [6] Progression-free survival (PFS) as a surrogate for overall survival (OS)
    Stewart, David J.
    Bosse, Dominick
    Hilton, John
    Goss, Glenwood
    Fung-Kee-Fung, Michael
    Jonker, Derek
    CANCER RESEARCH, 2018, 78 (13)
  • [7] ANALYSIS OF THE CORRELATION OF TIME TO TREATMENT FAILURE WITH OVERALL SURVIVAL VERSUS CORRELATION OF PROGRESSION-FREE SURVIVAL WITH OVERALL SURVIVAL
    Gibson, G. D.
    Henegan, J. C.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2022, 70 (02) : 548 - 548
  • [8] Increased EGFR expression is associated with reduced progression-free and overall survival rates
    Neumann, J.
    Herrmann, E.
    Korsching, E.
    Buerger, H.
    Bierer, S.
    Bocker, W.
    Wulfing, C.
    Eltze, E.
    PATHOLOGY RESEARCH AND PRACTICE, 2007, 203 (05) : 310 - 311
  • [9] Overall survival and progression-free survival in pediatric meningiomas: a systematic review and individual patient-level meta-analysis
    Wach, Johannes
    Vychopen, Martin
    Basaran, Alim Emre
    Tatagiba, Marcos
    Goldbrunner, Roland
    Gueresir, Erdem
    JOURNAL OF NEURO-ONCOLOGY, 2025, : 289 - 305
  • [10] Progression-free survival as a surrogate for overall survival in advanced cancer.
    Gillies, Eric
    Holdai, Veera
    Cowall, David Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345